Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α
Yuko Ono(Social Insurance Saitama Chuo Hospital), K. Sakamoto(International University of Health and Welfare)
Cited by 80
Related Papers
TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
|Scientific Reports|2020|153
C188-9, a specific inhibitor of STAT3 signaling, prevents thermal burn-induced skeletal muscle wasting in mice
|Frontiers in Pharmacology|2022|20